Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Whether you're getting started with PCR, sequencing, or diagnostics, tubes of custom DNA oligos will give you the exact, ...

Atea Pharmaceuticals, Inc.’s AVIR share price has surged by 5.33%, which has investors questioning if this is right time to sell.

A scientific statement regarding direct-to-consumer genetic testing for cardiovascular disease has been published by the AHA.

Vaccine-derived polioviruses were detected in wastewater samples from 5 European countries in late 2024, but no human cases were reported.

A recent study found two patients with a novel mutation in the RHCE gene, which codes for several antigens found on red blood cells.

The highest-ranking phenotypic predictors of head and neck cancer included past tobacco smoking, job code at baseline, pain experienced during the last month, qualifications, FVC (Z score), and blood ...

Researchers have identified mutations in the non-coding gene RNU2-2 as a cause of a newly defined neurodevelopmental disorder ...

Dallas-based biotech company Colossal has announced the birth of three pups bearing the DNA signatures of dire wolves, an ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

Sionna Therapeutics, Inc.’s SION share price has dipped by 9.01%, which has investors questioning if this is right time to ...